ArticleBlood2013

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.

Hugues de Lavallade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.